AP NEWS

Europe Limb-Girdle Muscular Dystrophy Market and Competitive Landscape - 2018 - ResearchAndMarkets.com

November 23, 2018

DUBLIN--(BUSINESS WIRE)--Nov 23, 2018--The “Europe Limb-Girdle Muscular Dystrophy Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

Europe Limb-Girdle Muscular Dystrophy Market and Competitive Landscape - 2018, provides comprehensive insights into Limb-Girdle Muscular Dystrophy pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.

This study accurately estimates and forecast Limb-Girdle Muscular Dystrophy market size and drug sales. This research also provides insights into Limb-Girdle Muscular Dystrophy epidemiology and late stage pipeline.

The research is classified into following sections - Limb-Girdle Muscular Dystrophy overview with definitions, symptoms, etiology, diagnosis, treatment options; Limb-Girdle Muscular Dystrophy pipeline insights covering late stage clinical trials pipeline; Limb-Girdle Muscular Dystrophy prevalence trends by countries; Limb-Girdle Muscular Dystrophy market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Key Topics Covered

1. Limb-Girdle Muscular Dystrophy: Disease Overview 1.1. Limb-Girdle Muscular Dystrophy Symptoms 1.2. Limb-Girdle Muscular Dystrophy Etiology 1.3. Limb-Girdle Muscular Dystrophy Diagnosis 1.4. Limb-Girdle Muscular Dystrophy Treatment Options

2. Limb-Girdle Muscular Dystrophy Pipeline Insights 2.1. Limb-Girdle Muscular Dystrophy Phase 3 Clinical Trials 2.2. Limb-Girdle Muscular Dystrophy Phase 2 Clinical Trials 2.3. Limb-Girdle Muscular Dystrophy Phase 1 Clinical Trials

3. Limb-Girdle Muscular Dystrophy Epidemiology Analysis

4. Germany Limb-Girdle Muscular Dystrophy Market Insights 4.1. Marketed Products for Limb-Girdle Muscular Dystrophy in Germany 4.2. Germany Limb-Girdle Muscular Dystrophy Market Size & Forecast 4.3. Germany Limb-Girdle Muscular Dystrophy Product Sales Forecast 4.4. Germany Limb-Girdle Muscular Dystrophy Market Share Analysis

5. France Limb-Girdle Muscular Dystrophy Market Insights 5.1. Marketed Products for Limb-Girdle Muscular Dystrophy in France 5.2. France Limb-Girdle Muscular Dystrophy Market Size & Forecast 5.3. France Limb-Girdle Muscular Dystrophy Product Sales Forecast 5.4. France Limb-Girdle Muscular Dystrophy Market Share Analysis

6. Italy Limb-Girdle Muscular Dystrophy Market Insights 6.1. Marketed Products for Limb-Girdle Muscular Dystrophy in Italy 6.2. Italy Limb-Girdle Muscular Dystrophy Market Size & Forecast 6.3. Italy Limb-Girdle Muscular Dystrophy Product Sales Forecast 6.4. Italy Limb-Girdle Muscular Dystrophy Market Share Analysis

7. Spain Limb-Girdle Muscular Dystrophy Market Insights 7.1. Marketed Products for Limb-Girdle Muscular Dystrophy in Spain 7.2. Spain Limb-Girdle Muscular Dystrophy Market Size & Forecast 7.3. Spain Limb-Girdle Muscular Dystrophy Product Sales Forecast 7.4. Spain Limb-Girdle Muscular Dystrophy Market Share Analysis

8. UK Limb-Girdle Muscular Dystrophy Market Insights 8.1. Marketed Products for Limb-Girdle Muscular Dystrophy in UK 8.2. UK Limb-Girdle Muscular Dystrophy Market Size & Forecast 8.3. UK Limb-Girdle Muscular Dystrophy Product Sales Forecast 8.4. UK Limb-Girdle Muscular Dystrophy Market Share Analysis

9. Europe Limb-Girdle Muscular Dystrophy Market Insights 9.1. Europe Limb-Girdle Muscular Dystrophy Market Size & Forecast 9.2. Europe Limb-Girdle Muscular Dystrophy Product Sales Forecast 9.3. Europe Limb-Girdle Muscular Dystrophy Market Share Analysis

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/2thtdf/europe?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181123005162/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs,Musculoskeletal Disorders Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/23/2018 09:21 AM/DISC: 11/23/2018 09:21 AM

http://www.businesswire.com/news/home/20181123005162/en

AP RADIO
Update hourly